Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TDOC
TDOC logo

TDOC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.030
Open
7.450
VWAP
7.68
Vol
8.36M
Mkt Cap
1.37B
Low
7.400
Amount
64.18M
EV/EBITDA(TTM)
--
Total Shares
180.51M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.
Show More

Events Timeline

(ET)
2026-05-28
11:20:00
BofA Bullish on Teladoc's Partnership with Walmart
select
2026-05-28
09:10:00
Teladoc Up 5% to $6.93 After Walmart Better Care Services Pact
select
2026-05-28
09:10:00
Teladoc Health Partners with Walmart to Offer Services
select
2026-05-14 (ET)
2026-05-14
09:20:00
BetterHelp Partners with Institute of Patient Safety and Quality of Virtual Care
select
2026-04-29 (ET)
2026-04-29
19:50:00
WTI Crude Oil Rises Above $108 for Third Consecutive Day
select
2026-04-29
16:20:00
Teladoc Health Reports Q1 Revenue of $613.8M
select

News

stocktwits
7.5
05-28stocktwits
Teladoc Partners with Walmart for Virtual Care Services
  • Partnership Expansion: Teladoc's collaboration with Walmart aims to provide virtual urgent care, dermatology, and nutrition services through the Better Care Services platform, targeting uninsured or underinsured demographics, which is expected to broaden its customer base.
  • Service Details: The offerings include 24/7 virtual urgent care, dermatology consultations with a 24-hour turnaround, and nutrition coaching, priced at $89 per visit, with prescriptions sent to any pharmacy, including Walmart.
  • Market Reaction: Following the announcement of the partnership, Teladoc's shares rose over 7%, surpassing the 200-day moving average, indicating a positive market response to the collaboration.
  • Strategic Implications: Bank of America views this partnership as a 'modest positive' for Teladoc, although it does not expect significant financial impacts in the near term; nonetheless, it enhances Teladoc's service integration within retail platforms, boosting brand visibility.
seekingalpha
7.5
05-28seekingalpha
Teladoc Partners with Walmart to Expand Virtual Care Services
  • Collaboration Expansion: Teladoc Health announced that its virtual care services are now available through Walmart's Better Care Services platform, aiming to enhance access to healthcare, particularly for uninsured customers.
  • Service Offerings: The new partnership allows Walmart customers to access various medical services, including 24/7 care, dermatology, and nutrition services, for $89 per visit, significantly improving the healthcare experience for shoppers.
  • Market Strategy: Teladoc's president, Kelly Bliss, emphasized that Walmart is a primary destination for everyday needs for millions of Americans, and integrating healthcare services into the shopping experience enhances brand penetration in the market.
  • Historical Collaborations: This partnership is part of Teladoc's ongoing collaboration with Walmart, following its 2025 partnership with Amazon to offer diabetes and hypertension management programs, showcasing its strategic positioning in retail and online platforms.
Fool
9.5
05-27Fool
Teladoc Health's Uncertain Future Raises Concerns
  • Subpar Financial Performance: In its first quarter update, Teladoc reported a 2% year-over-year revenue decline to $613.8 million, and while the net loss per share improved from $0.53 to $0.36, the company remains unprofitable, indicating significant challenges in regaining growth momentum.
  • Decline of BetterHelp Segment: Once a key growth driver, BetterHelp has seen both revenue and paying users drop by 9% year-over-year, highlighting difficulties in sustaining growth in a competitive market, which negatively impacts overall company performance.
  • International Expansion Potential: Despite overall struggles, Teladoc's international revenue increased by 17% year-over-year to $122.3 million, suggesting potential for future revenue growth as the company taps into global markets.
  • Uncertain Future of AI Tools: Teladoc's plans to introduce AI products to boost revenue face uncertainty regarding their effectiveness, and combined with ongoing losses and fierce competition, investors remain cautious about the company's ability to achieve profitability in the future.
NASDAQ.COM
9.5
05-27NASDAQ.COM
Teladoc Health Struggles with Financial Performance
  • Declining Financial Performance: Teladoc's stock has plummeted over 90% in the past five years, with Q1 revenue dropping 2% year-over-year to $613.8 million; despite an improvement in net loss per share from $0.53 to $0.36, the company remains unprofitable, indicating ongoing financial struggles.
  • BetterHelp Segment Decline: Once a key growth driver, BetterHelp has seen both revenue and paying users decline by 9% year-over-year, highlighting challenges in sustaining growth in a competitive market, which adversely affects overall performance.
  • International Expansion Potential: Despite poor overall performance, Teladoc's international revenue rose 17% year-over-year to $122.3 million, indicating potential for future revenue growth as the company taps into global markets.
  • Uncertain Future of AI Tools: Teladoc plans to introduce a range of AI products to boost revenue; however, given the company's history of consistent losses and intense market competition, the success of this strategy remains highly uncertain.
Yahoo Finance
9.5
05-18Yahoo Finance
Teladoc Stock Underperforms, Caution Advised for Investors
  • Weak Revenue Growth: Teladoc's sales of $2.51 billion over the past 12 months are nearly unchanged from three years ago, indicating a lack of long-term revenue growth and suggesting lower overall business quality, which may undermine investor confidence.
  • Declining User Spending: The average revenue per user (ARPU) has decreased by an average of 9% annually over the past two years, raising concerns about user engagement and signaling a potential erosion of the platform's value, which could impact future revenue growth.
  • Soft Future Revenue Projections: Wall Street analysts expect Teladoc's revenue to stagnate over the next 12 months, a forecast that fails to excite the market and suggests that its newer products and services are not poised to accelerate revenue growth, potentially putting pressure on the stock price.
  • Poor Market Performance: Currently trading at $6.81 per share with a forward EV/EBITDA of 5.1x, Teladoc's valuation appears fair, but the limited upside compared to potential downside risks suggests investors should consider more attractive investment opportunities.
seekingalpha
2.0
05-08seekingalpha
Teladoc Health Shares Rise for Seven Consecutive Days
  • Stock Price Surge: Teladoc Health's shares rose over 4% on Friday, marking a seven-day winning streak, with a 22% increase since April 30, climbing from $5.95 to approximately $7.30, indicating strong market optimism about its future prospects.
  • Strong Monthly Performance: Over the past month, Teladoc's stock has gained 38%, although it is up only 2.7% year-to-date, trailing the S&P 500's approximately 7% gains, reflecting a need for improvement in its relative market performance.
  • Business Model Transformation: Analysts highlight that Teladoc is transitioning from a cyclical direct-to-consumer telehealth model to a higher-margin, data-driven business-to-business healthcare platform, which could enhance its long-term profitability and market valuation.
  • Improved Financial Health: With improving EBITDA margins, positive free cash flow, and a stronger balance sheet, Teladoc is seen as entering a more scalable profitability phase, supporting potential future valuation re-ratings.
Wall Street analysts forecast TDOC stock price to rise
15 Analyst Rating
Wall Street analysts forecast TDOC stock price to rise
3 Buy
12 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Current: 0.000
sliders
Low
7.50
Averages
8.91
High
12.00
Goldman Sachs
Buy
maintain
$7 -> $8
AI Analysis
2026-05-27
New
Reason
Goldman Sachs
Price Target
$7 -> $8
AI Analysis
2026-05-27
New
maintain
Buy
Reason
Goldman Sachs raised the firm's price target on Teladoc to $8 from $7 and keeps a Buy rating on the shares. MedTech has experienced one of its weakest periods in 15-20 years across performance, valuation, and outlook revisions, pressured by sector rotation, slower growth, reimbursement and competitive risks, and aging investment narratives, the analyst tells investors in a research note.
Citi
Neutral
maintain
$6 -> $7
2026-05-05
Reason
Citi
Price Target
$6 -> $7
2026-05-05
maintain
Neutral
Reason
Citi raised the firm's price target on Teladoc to $7 from $6 and keeps a Neutral rating on the shares post the Q' report. The firm cites BetterHelp's better than expected results for the target boost.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TDOC
Unlock Now

Valuation Metrics

The current forward P/E ratio for Teladoc Health Inc (TDOC.N) is 303.03, compared to its 5-year average forward P/E of 3.24. For a more detailed relative valuation and DCF analysis to assess Teladoc Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
3.24
Current PE
303.03
Overvalued PE
97.18
Undervalued PE
-90.70

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
20.29
Current EV/EBITDA
9.09
Overvalued EV/EBITDA
41.68
Undervalued EV/EBITDA
-1.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.28
Current PS
0.50
Overvalued PS
5.14
Undervalued PS
-0.58

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

best swing trades
Intellectia · 40 candidates
Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $5.00 - $18.00One Week Rise Prob: >= 70Monthly Average Dollar Volume: >= 1,500,000
Ticker
Name
Market Cap$
top bottom
TALK logo
TALK
Talkspace Inc
856.44M
ACRS logo
ACRS
Aclaris Therapeutics Inc
435.91M
PHIO logo
PHIO
Phio Pharmaceuticals Corp
14.64M
WTI logo
WTI
W&T Offshore Inc
424.02M
TURB logo
TURB
Turbo Energy SA
41.20M
OLN logo
OLN
Olin Corp
2.70B
what are some day trades i can do with 300$
Intellectia · 122 candidates
Region: USPrice: $1.00 - $30.00Price Change Pct: $3.00 - $100.00Relative Vol: >= 1.50Beta: HighRiskList Exchange: XNYS, XNAS, XASE
Ticker
Name
Market Cap$
top bottom
UWMC logo
UWMC
UWM Holdings Corp
6.66B
PATH logo
PATH
UiPath Inc
5.32B
AAL logo
AAL
American Airlines Group Inc
8.80B
OPEN logo
OPEN
Opendoor Technologies Inc
4.77B
RGTI logo
RGTI
Rigetti Computing Inc
5.82B
LUNR logo
LUNR
Intuitive Machines Inc
3.23B

Whales Holding TDOC

T
Tang Capital Management, LLC
Holding
TDOC
+2.01%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Teladoc Health Inc (TDOC) stock price today?

The current price of TDOC is 7.61 USD — it has increased 1.33

What is Teladoc Health Inc (TDOC)'s business?

Teladoc Health, Inc. provides virtual healthcare services. Its segments include Teladoc Health Integrated Care (Integrated Care) and BetterHelp. Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed on a B2B basis. BetterHelp segment includes direct-to-consumer mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs. Its Telecare brand is a tech-enabled provider of specialist and allied health care via virtual delivery.

What is the price predicton of TDOC Stock?

Wall Street analysts forecast TDOC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TDOC is8.91 USD with a low forecast of 7.50 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Teladoc Health Inc (TDOC)'s revenue for the last quarter?

Teladoc Health Inc revenue for the last quarter amounts to 613.85M USD, decreased -2.47

What is Teladoc Health Inc (TDOC)'s earnings per share (EPS) for the last quarter?

Teladoc Health Inc. EPS for the last quarter amounts to -0.36 USD, decreased -32.08

How many employees does Teladoc Health Inc (TDOC). have?

Teladoc Health Inc (TDOC) has 5600 emplpoyees as of May 31 2026.

What is Teladoc Health Inc (TDOC) market cap?

Today TDOC has the market capitalization of 1.37B USD.